GB201009037D0 - Compositions and methods for treating disorders associated with atherosclerotic plaques - Google Patents
Compositions and methods for treating disorders associated with atherosclerotic plaquesInfo
- Publication number
- GB201009037D0 GB201009037D0 GBGB1009037.1A GB201009037A GB201009037D0 GB 201009037 D0 GB201009037 D0 GB 201009037D0 GB 201009037 A GB201009037 A GB 201009037A GB 201009037 D0 GB201009037 D0 GB 201009037D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- methods
- disorders associated
- treating disorders
- atherosclerotic plaques
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009037.1A GB201009037D0 (en) | 2010-05-28 | 2010-05-28 | Compositions and methods for treating disorders associated with atherosclerotic plaques |
PCT/GB2011/000815 WO2011148147A1 (en) | 2010-05-28 | 2011-05-27 | Compositions and methods for treating disorders associated with atherosclerotic plaques |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1009037.1A GB201009037D0 (en) | 2010-05-28 | 2010-05-28 | Compositions and methods for treating disorders associated with atherosclerotic plaques |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201009037D0 true GB201009037D0 (en) | 2010-07-14 |
Family
ID=42371215
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1009037.1A Ceased GB201009037D0 (en) | 2010-05-28 | 2010-05-28 | Compositions and methods for treating disorders associated with atherosclerotic plaques |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201009037D0 (en) |
WO (1) | WO2011148147A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019246282A1 (en) | 2018-06-19 | 2019-12-26 | The Regents Of The University Of Colorado | Protection from stress, anxiety, neuroinflammation and cognitive dysfunction |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2046830C (en) | 1990-07-19 | 1999-12-14 | Patrick P. Deluca | Drug delivery system involving inter-action between protein or polypeptide and hydrophobic biodegradable polymer |
DK0814778T3 (en) | 1995-03-10 | 2001-09-17 | Roche Diagnostics Gmbh | Polypeptide-containing pharmaceutical administration forms in the form of microparticles and their method of preparation |
US20030219453A1 (en) * | 1998-03-19 | 2003-11-27 | Smithkline Beecham Biologicals, Sa | Vaccines |
AU766959B2 (en) | 1998-04-20 | 2003-10-30 | Genzyme Corporation | Drug delivery of proteins from polymeric blends |
-
2010
- 2010-05-28 GB GBGB1009037.1A patent/GB201009037D0/en not_active Ceased
-
2011
- 2011-05-27 WO PCT/GB2011/000815 patent/WO2011148147A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2011148147A1 (en) | 2011-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1246715A1 (en) | Compositions and methods for targeted thermomodulation | |
HK1174064A1 (en) | Methods and compositions for cell-proliferation-related disorders | |
IL226401A0 (en) | Methods of treating fgf21-associated disorders | |
EP2406389A4 (en) | Methods and compositions for cell-proliferation-related disorders | |
EP2552433A4 (en) | Compositions and methods for the treatment of somatosensory disorders | |
HK1203830A1 (en) | Compositions and methods for treating metabolic disorders | |
EP2655334A4 (en) | Compositions and methods useful for treating diseases | |
EP2797620A4 (en) | Methods and compositions for treating ineffective erythropoiesis | |
ZA201303423B (en) | Compositions and methods for treating myelofibrosis | |
HRP20181950T1 (en) | Samidorphan (alks 33) in combination with buprenorphine for the treatment of depressive disorders | |
ZA201304334B (en) | Methods for diagnosing and treating eye-length related disorders | |
EP2523553A4 (en) | Methods and compositions for treating bleeding disorders | |
EP2550361A4 (en) | Compositions and methods for treating neurological disorders | |
EP2590674A4 (en) | Compositions and methods for treating influenza | |
ZA201203002B (en) | Compositions and methods for treating inflammatory disorders | |
HK1179823A1 (en) | Methods for treating methotrexate-resistant disorders with 10-propargyl-10- deazaaminopterin 10--10- | |
WO2011112588A9 (en) | Compositions and methods for treating inflammatory disorders | |
EP2558622A4 (en) | Compositions and methods for identifying autism spectrum disorders | |
EP2688585A4 (en) | Methods and compositions for improving antiangiogenic therapy with anti-integrins | |
EP2473171A4 (en) | Methods of treating mitochondrial disorders using metalloporhyrins | |
AP2013007056A0 (en) | Methods and compositions for treating kidney disorders | |
EP2643470A4 (en) | Compositions and methods for diagnosing and treating diseases and disorders associated with d-dt | |
GB201009037D0 (en) | Compositions and methods for treating disorders associated with atherosclerotic plaques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |